|
Guest
Although Rajasthan Government has taken an initiative towards prescribing generic products, there are some brands which are not approved by any Pharmacopoeia but still available in the market (Lifeline and Co-operative Stores of Rajasthan). Patients will be deprived of quality brands as these are marginally higher priced. Rhoclone is a brand which contains anti-D Immune globulin which is not approved by any pharmacopoeia but if "anti-D" generic is prescribed by doctors, they will not necessarily get a Pharmacopoeia approved product.
Hence before taking such steps, Rajasthan Government should not allow Non-Pharmacopoeial product in the market.
|
Replied on Tuesday, June 12, 2007 12:00 AM
|
|
|
Guest
Rhoclone is a Monoclonal Anti-D for whcih even all the four phase clinical trials are not completed. Researcher BM Kumpel mentions that some Heterohibridome Monoclonal in fact enhences immune response which is exactly the opposite action of such drugs. How Govt of India could allow manufacturing of this product in India is the biggest riddle when this drug is not approved in US, Canada, UK Australia for use as Immune Prophylaxis.
|
Replied on Saturday, May 24, 2008 12:00 AM
|
|
|
|